Good news for CMT 1A and 1B

Published on January 7th, 2020

InFlectis BioScience Announces Successful Completion of Phase 1 Clinical Trial of Oral IFB-088

For more informations, follow the link: https://bit.ly/2QNzl9W

or visit InFlectis BioScience web site: http://www.inflectisbioscience.com/

To read latest news

  • March 5th, 2021

    Faces of CMT & RDD

    All entries...
  • January 31st, 2021

    Faces of CMT

    We are happy to launch this international photographic competition, open to everyone,...
  • November 19th, 2020

    CMT Gene Therapy

    European Associations’ support to research on CMT